Heres what they discovered: Those on semaglutide or tirzepatide had a: 37% lower risk of developing dementia 19% lower risk of having a stroke 30% lower risk of dying from any cause Thats big news, especially for stroke survivors trying to stay ahead of the curve
The key differences between them come down to dosage, branding, and intended use
Tirzepatide GLP-1 + GIP Dual Agonist Does everything semaglutide does, plus mimics a second hormone: GIP (glucose-dependent insulinotropic polypeptide)
However, the liraglutide group showed a significantly greater increase in fibrous-plaque volume
A method of preparing medications to meet you specifically
Although primarily approved for managing type 2 diabetes, Ozempic has gained recognition for its significant appetite-suppressing benefits, making it a valuable addition to personalized weight-loss plans